Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.


CSE:SONA - Post by User

Bullboard Posts
Comment by bluebeard123on Apr 15, 2020 11:15pm
148 Views
Post# 30914634

RE:Throwing out some numbers

RE:Throwing out some numbers I hope you are right. If just sounds too good to be true. $10 net profit may be too high. Cost of goods would include payments to contract manufacturers, payments to GE and other partners, and distribution costs. Then there's overhead, R & D (significant for medical company), sales cost and marketing costs (significant) and taxes. It would be interesting to see the income statement. However I think your P/E of 10 is too low. For a high growth company, it would be closer to 40. Quite frankly, I would not know how to value this company this way. Because this company has not yet generated any income, I think the market would value the company based on sales, typically 3-5X sales. High growth would give a higher multiple. If we use 5X sales, and initial sales are $100M, then the company would have a market cap of $500M. With 50M shares outstanding, it would mean a share price of $10. I don't know. I would certainly take $100 per share using your method. I hope you are right.
Bullboard Posts